Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis
Open Access
- 30 June 2021
- journal article
- review article
- Published by Springer Nature in Systematic Reviews
- Vol. 10 (1) , 1-15
Abstract
Background: Comprehensive evidence synthesis on the associations between comorbidities and behavioural factors with hospitalisation, intensive care unit (ICU) admission, and death due to COVID-19 is required for deriving national and international recommendations on primary targets for non-pharmacological interventions (NPI) and vaccination strategies. Methods: We performed a rapid systematic review and meta-analysis on studies and publicly accessible data to quantify associations between predisposing health conditions, demographics, behavioural factors on the one hand and hospitalisation, ICU admission, and death from COVID-19 on the other hand. We provide ranges of reported and calculated effect estimates and pooled relative risks derived from a meta-analysis and meta-regression. Results: Seventy-five studies were included in qualitative and 74 in quantitative synthesis, with study populations ranging from 19 to 44,672 COVID-19 cases. The risk of dying from COVID-19 was significantly associated with cerebrovascular [pooled relative risk (RR) 2.7 (95% CI 1.7–4.1)] and cardiovascular [RR 3.2 (CI 2.3–4.5)] diseases, hypertension [RR 2.6 (CI 2.0–3.4)], and renal disease [RR 2.5 (CI 1.8–3.4)], with high heterogeneity in pooled estimates, partly but not solely explained by age of study participants. For some comorbidities, our meta-regression showed a decrease in effect on the severity of disease with a higher median age of the study population. Compared to death, associations between several comorbidities and hospitalisation and ICU admission were less pronounced. Conclusions: We obtained robust estimates on the magnitude of risk for COVID-19 hospitalisation, ICU admission, and death associated with comorbidities, demographic, and behavioural risk factors and show that these estimates are modified by age of study participants. This interaction is an important finding to be kept in mind for current vaccination strategies and for the protection of individuals with high risk for a severe COVID-19 course.Keywords
All Related Versions
Funding Information
- H2020 European Research Council (101003480)
- Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
This publication has 40 references indexed in Scilit:
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsBMJ, 2016
- Ageing and the epidemiology of multimorbidityEuropean Respiratory Journal, 2014
- Guidelines for snowballing in systematic literature studies and a replication in software engineering2014
- Change in Comorbidity Prevalence with Advancing Age Among Persons with Heart FailureJournal of General Internal Medicine, 2011
- The changing prevalence of comorbidity across the age spectrumCritical Reviews in Oncology/Hematology, 2008
- ACE2: from vasopeptidase to SARS virus receptorTrends in Pharmacological Sciences, 2004
- Cellular and Structural Bases of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Diabetes mellitus Induces a Thickening of the Pulmonary Basal LaminaRespiration, 1999
- Standardized Mortality Ratios and the "Healthy Worker Effect": Scratching Beneath the SurfaceJournal of Occupational and Environmental Medicine, 1976